Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

14:30 EDT 17th April 2014 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 3,700+

Sunday 13th April 2014

Dumbo Feather Magazine Features Beacon Cove Dental's Principal Dentist Fern White's Unique Story

Beacon Cove Dental's principal dentist Fern White was featured in the 38th issue of the popular Dumbo Feather magazine. She was interviewed about her business, life and family with a special focus on her story as a refugee from Vietnam in the early 80's. Melbourne, Australia (PRWEB) April 14, 2014 Extraordinary people seeking refuge in Australia are interviewed in the 38th issue of the we...

Sebelius: Website Launch 'Terribly Flawed And Terribly Difficult'

In an interview broadcast on "Meet the Press," the outgoing HHS secretary says the decision to leave office was hers. The Associated Press: Sebelius: Health Care Launch 'Terribly Flawed' Outgoing Health and Human Services Secretary Kathleen Sebelius says the administration's own predictions that the new health care law's online sign-up system would be ready by Oct. 1 were "just flat out wrong." S...

Friday 11th April 2014

Optimization of heterologous protein production in Chinese hamster ovary cells under overexpression of spliced form of human X-box binding protein

Background: The optimization of protein production is a complex and challenging problem in biotechnology. Different techniques for transcription, translation engineering and the optimization of cell culture conditions have been used to improve protei...

Tissue Diagnostics Market Worth $3,924.01 Million by 2018

DALLAS, April 11, 2014 /PRNewswire/ -- The "Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laborato...

California Healthcare Institute Adds Five Industry Leaders to its Board

CHI announced today the election of five senior executives to serve on its board of directors. La Jolla, CA (PRWEB) April 11, 2014 California Healthcare Institute (CHI) announced today the election of five senior executives to serve on its board of directors: Jeffrey D. Armstrong, Ph.D., president, California Polytechnic State University, San Luis Obispo; Donald E. Bobo, Jr., corporate vice presi...

Nexstim Selected as a 2014 Red Herring Top 100 Europe

The Only Medical Device Company Awarded Red Herring’s Top 100 Europe celebrates the exceptional accomplishments of technology companies and their position to grow at an explosive rate. The awards winners were announced today, and Nexstim has proudly been selected in this prestigious group as a Top 100 Europe. “I’m very excited about this...

Stock offering brings in $137.7M for Exact Sciences

Wisconsin-based molecular-diagnostics-maker Exact Sciences secured $137.7 million in net proceeds from a public shares offeri -More- 

Brain Imaging Tracer for Parkinson's Disease

LA JOLLA, Calif., April 11, 2014 /PRNewswire-iReach/ -- On March 4, 2014, ICB International, Inc., ("ICBI"), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in Parkinson's-like mice at the Keystone Symposium for Parkinson disease (PD) in Keystone,Colorado. Speaking at the symposium, Dr. Anna Cartier, Associate Director of ICBI, presented scientific data and showed images...

UCLA to Build Pathology Lab in Shanghai with Centre Testing Intl.

The University of California’s Department of Pathology will set up a clinical lab in Shanghai with Centre Testing International, a Chinese company that offers product testing. The new lab, CTI-Pathology/UCLA Health, will operate a 25,000-square...

Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018

Recently added to the BioPortfolio report store, Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 is a new report from Markets and Markets published on 2014-04-04. This report is available in pdf from $4...

Thursday 10th April 2014

ERBA Diagnostics, Inc. Announces Timeframe within Which It Intends to File Its Annual Report on Form 10-K

ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, announced that it intends to file its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission (the “SEC”) on Monday, April 14, 2014. Pursuant to Rule 12b-25 under the Securities Exchange Act of 1934, by vi...

SQI Diagnostics completes equity financing

SQI Diagnostics (TSX-V:SQD) has closed a public offering of 8.4 million units at a price of 50 cents each for gross proceeds of $4.2-million. Each unit consists of one common share and one warrant, which can be exercised to purchase an additional common share at a price of 65 cents until April 10, 2016. Proceeds […]

Concurrent with founding, NeuMoDx raises $5mm in Series A financing

Molecular diagnostics start-up NeuMoDx Molecular Inc. raised $5mm in a three-tranche Series A financing from Arboretum Ventures and Wolverine Venture Fund, which is run by students from the University of Michigan’s Stephen M. Ross School of Busines...

Almirall gets European license to InDex's Kappaproct

InDex Pharmaceuticals AB (synthetic oligonucleotides for ulcerative colitis and pulmonary inflammation, and companion diagnostics) licensed Spanish firm Almirall SA rights to market its Phase III ulcerative colitis (UC) candidate Kappaproct in Europe...

Adaptive Biotechnologies raises $5mm through Series C; later adds $5mm more

Adaptive Biotechnologies Corp. (formerly Adaptive TCR; immune system profiling for diagnostics and drug development) raised $5mm from three investors in its Series C round.

Series B brings $5.8mm to Adaptive TCR

Immunosequencing firm Adaptive TCR Corp. raised $5.8mm from 63 private investors in its Series B round. Proceeds will fund continued development of the company's flagship product immunoSEQ, an immune system profiling assay that analyzes T and B cells...

Polysciences, Inc. Appoints Dr. Joël Coret as New Chief Technology Officer

Dr. Joël Coret will take over for Dr. Robert Gleim, who retired in March, as CTO and VP of the Custom Synthesis Division at Polysciences, Inc. Dr. Coret brings a wealth of experience in the research and development of active delivery and novel formulation technologies. Warrington, PA (PRWEB) April 10, 2014 Polysciences, Inc., an award-winning company specializing in the development and manuf...

QIAGEN Adds Promising New Biomarker to Pipeline of Personalized Healthcare Assays to Improve Diagnosis of Blood Disorders

HILDEN, Germany and VIENNA, April 10, 2014 /PRNewswire/ --  Reliable diagnostic tools under development for mutations of calreticulin (CALR) are expected to benefit patients with blood disorders known as myeloproliferative neoplasms  QIAGEN acquired exclusive worldwide license for CALR biomarker from CeMM Vienna, whose researchers recently published the discovery in the New E...

Indiana diagnostics startup seeks $750K to validate colon cancer monitoring test

“MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences” An Indiana life sciences company looks at metabolites as...

Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo

Pancreatic cancer remains a major unsolved health problem lacking a potent therapeutic option. Our previous studies showed that the ribosomal protein L39 (RPL39) gene was up‐regulated after long‐term silencing of oncogenic KRAS in pancreatic canc...

Absolute Antibody Receives £850K ($1.4M) Funding (News)

09 April 2014: Oxford, UK - Absolute Antibody Ltd, a life sciences company developing next generation engineered antibodies for biomedical research and diagnostics markets, announced that it ...

Thought Leaders are Optimistic that Emerging Therapies will Offer Efficacy Benefits Over Current Therapies for Metastatic Gastric Cancer; Augmenting Biomarker-Driven Prescribing

BURLINGTON, Mass., April 10, 2014 /PRNewswire/ -- Decision Resources Group finds that interviewed oncologists are optimistic that emerging targeted therapies will offer efficacy advantages over current treatment options for metastatic gastric cancer. Physicians anticipate that Roche/Genentech/Chugai's Perjeta and Roche/Genentech/Chugai's Kadcyla will join Roche/Genentech/Chugai's Herceptin in...

California Healthcare Institute Honors Representatives Scott Peters & David Valadao

California Legislators Named 2014 Visionary Award Winners La Jolla, CA (PRWEB) April 10, 2014 Yesterday, California Congressmen Scott Peters (D-52) and David Valadao (R-21) were honored by the California Healthcare Institute (CHI) for their leadership in promoting thoughtful policies to advance biomedical research, investment and innovation over the past year. CHI is a nonprofit, public policy re...

ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System / T-Wave Morphology Analysis

Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development Philadelphia (PRWEB) April 10, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced it has entered into an agreement with GE Healthcare that enables ERT to introduce the QT Guard Plus Analysis System to the clinical trial...

T2 Biosystems Presents New Data at the Thrombosis and Hemostasis Summit of North America Demonstrating Ability of T2MR Platform Technology to Measure Platelet Activity and Additional Hemostasis Parameters

-Presentations Feature Use of Investigational T2Stat Instrument and T2HemoStat Panel to Provide Rapid Diagnostic Results From Whole Blood on a Single, Compact Instrument- T2 Biosystems, a company developing direct detection products designed to enable superior diagnostics, today announced the presentation of data highlighting the role of its T2MR platf...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement